{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T15:13:38Z","timestamp":1790867618327,"version":"4.1.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003136","name":"Edmond J Safra Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003136","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100030956","name":"Fundaci\u00f3 Clinic per la Recerca Biom\u00e8dica","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100030956","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Clinics of North America"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.mcna.2024.09.001","type":"journal-article","created":{"date-parts":[[2025,1,4]],"date-time":"2025-01-04T12:44:25Z","timestamp":1735994665000},"page":"443-461","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Autoimmune Encephalitis"],"prefix":"10.1016","volume":"109","author":[{"given":"Mar","family":"Guasp","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josep","family":"Dalmau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.mcna.2024.09.001_bib1","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1056\/NEJMra1708712","article-title":"Antibody-mediated encephalitis","volume":"378","author":"Dalmau","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.mcna.2024.09.001_bib2","doi-asserted-by":"crossref","unstructured":"Dalmau J, Graus F. Autoimmune encephalitis and related disorders of the nervous system. 1st ed, Cambridge, UK, Cambridge University Press 2022.","DOI":"10.1017\/9781108696722"},{"issue":"1","key":"10.1016\/j.mcna.2024.09.001_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1212\/NXI.0000000000000514","article-title":"Management and prognostic markers in patients with autoimmune encephalitis requiring ICU treatment","volume":"6","author":"Schubert","year":"2019","journal-title":"Neurol Neuroimmunol NeuroInflammation"},{"issue":"10172","key":"10.1016\/j.mcna.2024.09.001_bib4","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S0140-6736(18)32526-1","article-title":"Acute encephalitis in immunocompetent adults","volume":"393","author":"Venkatesan","year":"2019","journal-title":"Lancet (London, England)"},{"issue":"12","key":"10.1016\/j.mcna.2024.09.001_bib5","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/S1473-3099(10)70222-X","article-title":"Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study","volume":"10","author":"Granerod","year":"2010","journal-title":"Lancet Infect Dis"},{"issue":"7","key":"10.1016\/j.mcna.2024.09.001_bib6","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1093\/cid\/cir1038","article-title":"The frequency of autoimmune N-methyl-D-aspartate receptor encephalitis surpasses that of individual viral etiologies in young individuals enrolled in the California Encephalitis Project","volume":"54","author":"Gable","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.mcna.2024.09.001_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1212\/NXI.0000000000000883","article-title":"Epidemiology of paraneoplastic neurologic syndromes and autoimmune encephalitides in France","volume":"7","author":"H\u00e9bert","year":"2020","journal-title":"Neurol Neuroimmunol neuroinflammation"},{"issue":"2","key":"10.1016\/j.mcna.2024.09.001_bib8","doi-asserted-by":"crossref","first-page":"e1127","DOI":"10.1212\/NXI.0000000000001127","article-title":"Anti-NMDAR encephalitis in The Netherlands, focusing on late-onset patients and antibody test accuracy","volume":"9","author":"Bastiaansen","year":"2022","journal-title":"Neurol Neuroimmunol NeuroInflammation"},{"issue":"14","key":"10.1016\/j.mcna.2024.09.001_bib9","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1212\/WNL.0000000000003173","article-title":"Anti-LGI1 encephalitis: clinical syndrome and long-term follow-up","volume":"87","author":"Van Sonderen","year":"2016","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.mcna.2024.09.001_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1212\/NXI.0000000000200129","article-title":"Frequency and referral patterns of neural antibody studies during the COVID-19 pandemic: experience from an autoimmune neurology center","volume":"10","author":"Ari\u00f1o","year":"2023","journal-title":"Neurol Neuroimmunol neuroinflammation"},{"issue":"1","key":"10.1016\/j.mcna.2024.09.001_bib11","doi-asserted-by":"crossref","first-page":"e200182","DOI":"10.1212\/NXI.0000000000200182","article-title":"Antibody investigations in 2,750 children with suspected autoimmune encephalitis","volume":"11","author":"Chen","year":"2024","journal-title":"Neurol Neuroimmunol neuroinflammation"},{"issue":"9","key":"10.1016\/j.mcna.2024.09.001_bib12","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S1474-4422(18)30244-8","article-title":"Frequency, symptoms, risk factors, and outcomes of autoimmune encephalitis after herpes simplex encephalitis: a prospective observational study and retrospective analysis","volume":"17","author":"Armangue","year":"2018","journal-title":"Lancet Neurol"},{"issue":"10","key":"10.1016\/j.mcna.2024.09.001_bib13","doi-asserted-by":"crossref","first-page":"4306","DOI":"10.1093\/brain\/awad238","article-title":"Neurologic complications in herpes simplex encephalitis: clinical, immunological and genetic studies","volume":"146","author":"Armangue","year":"2023","journal-title":"Brain"},{"issue":"9","key":"10.1016\/j.mcna.2024.09.001_bib14","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/s41571-019-0194-4","article-title":"Paraneoplastic neurological syndromes in the era of immune-checkpoint inhibitors","volume":"16","author":"Graus","year":"2019","journal-title":"Nat Rev Clin Oncol"},{"issue":"3","key":"10.1016\/j.mcna.2024.09.001_bib15","doi-asserted-by":"crossref","first-page":"e974","DOI":"10.1212\/NXI.0000000000000974","article-title":"Clinical and prognostic value of immunogenetic characteristics in anti-LGI1 encephalitis","volume":"8","author":"Mu\u00f1iz-Castrillo","year":"2021","journal-title":"Neurol Neuroimmunol neuroinflammation"},{"issue":"6","key":"10.1016\/j.mcna.2024.09.001_bib16","doi-asserted-by":"crossref","first-page":"e605","DOI":"10.1212\/NXI.0000000000000605","article-title":"HLA and microtubule-associated protein tau H1 haplotype associations in anti-IgLON5 disease","volume":"6","author":"Gaig","year":"2019","journal-title":"Neurol Neuroimmunol neuroinflammation"},{"issue":"10","key":"10.1016\/j.mcna.2024.09.001_bib17","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1136\/jnnp-2020-323226","article-title":"Anti-CASPR2 clinical phenotypes correlate with HLA and immunological features","volume":"91","author":"Mu\u00f1iz-Castrillo","year":"2020","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"4","key":"10.1016\/j.mcna.2024.09.001_bib18","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","article-title":"A\u00a0clinical approach to diagnosis of autoimmune encephalitis","volume":"15","author":"Graus","year":"2016","journal-title":"Lancet Neurol"},{"issue":"11","key":"10.1016\/j.mcna.2024.09.001_bib19","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1212\/WNL.0000000000003713","article-title":"Investigations in GABA A receptor antibody-associated encephalitis","volume":"88","author":"Spatola","year":"2017","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.mcna.2024.09.001_bib20","first-page":"3337","article-title":"Use of diffusion-weighted imaging to distinguish seizure-related change from limbic encephalitis","volume":"267","author":"Budhram","year":"2020","journal-title":"J\u00a0Neurol"},{"issue":"1","key":"10.1016\/j.mcna.2024.09.001_bib21","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S1474-4422(10)70253-2","article-title":"Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis","volume":"10","author":"Dalmau","year":"2011","journal-title":"Lancet Neurol"},{"issue":"7","key":"10.1016\/j.mcna.2024.09.001_bib22","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1136\/jnnp-2011-301969","article-title":"Fluorodeoxyglucose positron emission tomography in anti-N-methyl-D-aspartate receptor encephalitis: distinct pattern of disease","volume":"83","author":"Leypoldt","year":"2012","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"3","key":"10.1016\/j.mcna.2024.09.001_bib23","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S1474-4422(23)00463-5","article-title":"Neurological, psychiatric, and sleep investigations after treatment of anti-leucine-rich glioma-inactivated protein 1 (LGI1) encephalitis in Spain: a prospective cohort study","volume":"23","author":"Mu\u00f1oz-Lopetegi","year":"2024","journal-title":"Lancet Neurol"},{"issue":"11","key":"10.1016\/j.mcna.2024.09.001_bib24","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1212\/WNL.0b013e3182698cd8","article-title":"Extreme delta brush: a unique EEG pattern in adults with anti-NMDA receptor encephalitis","volume":"79","author":"Schmitt","year":"2012","journal-title":"Neurology"},{"issue":"June","key":"10.1016\/j.mcna.2024.09.001_bib25","first-page":"1","article-title":"Limitations of a commercial assay as diagnostic test of autoimmune encephalitis","volume":"12","author":"Ruiz-Garc\u00eda","year":"2021","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.mcna.2024.09.001_bib26","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S1474-4422(23)00083-2","article-title":"Diagnostic criteria for autoimmune encephalitis: utility and pitfalls for antibody-negative disease","volume":"22","author":"Dalmau","year":"2023","journal-title":"Lancet Neurol"},{"issue":"1","key":"10.1016\/j.mcna.2024.09.001_bib27","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1001\/jamaneurol.2022.4251","article-title":"Autoimmune encephalitis misdiagnosis in adults","volume":"80","author":"Flanagan","year":"2023","journal-title":"JAMA Neurol"},{"issue":"4","key":"10.1016\/j.mcna.2024.09.001_bib28","doi-asserted-by":"crossref","first-page":"e1014","DOI":"10.1212\/NXI.0000000000001014","article-title":"Updated diagnostic criteria for paraneoplastic neurologic syndromes","volume":"8","author":"Graus","year":"2021","journal-title":"Neurol Neuroimmunol neuroinflammation"},{"issue":"2","key":"10.1016\/j.mcna.2024.09.001_bib29","doi-asserted-by":"crossref","first-page":"E217","DOI":"10.1212\/WNL.0000000000008785","article-title":"Hashimoto encephalopathy in the 21st century","volume":"94","author":"Mattozzi","year":"2020","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.mcna.2024.09.001_bib30","doi-asserted-by":"crossref","first-page":"e663","DOI":"10.1212\/NXI.0000000000000663","article-title":"Clinical approach to the diagnosis of autoimmune encephalitis in the pediatric patient","volume":"7","author":"Cellucci","year":"2020","journal-title":"Neurol Neuroimmunol neuroinflammation"},{"key":"10.1016\/j.mcna.2024.09.001_bib31","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1474-4422(12)70310-1","article-title":"Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study","volume":"12","author":"Titulaer","year":"2013","journal-title":"Lancet Neurol"},{"issue":"11","key":"10.1016\/j.mcna.2024.09.001_bib32","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S1474-4422(19)30244-3","article-title":"An update on anti-NMDA receptor encephalitis for neurologists and psychiatrists: mechanisms and models","volume":"18","author":"Dalmau","year":"2019","journal-title":"Lancet Neurol"},{"issue":"10","key":"10.1016\/j.mcna.2024.09.001_bib33","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S1474-4422(22)00299-X","article-title":"Clinical characterisation of patients in the post-acute stage of anti-NMDA receptor encephalitis: a prospective cohort study and comparison with patients with schizophrenia spectrum disorders","volume":"21","author":"Guasp","year":"2022","journal-title":"Lancet Neurol"},{"issue":"9","key":"10.1016\/j.mcna.2024.09.001_bib34","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1001\/jamaneurol.2013.3216","article-title":"Frequency and characteristics of isolated psychiatric episodes in anti\u2013N-methyl- d -aspartate receptor encephalitis","volume":"70","author":"Kayser","year":"2013","journal-title":"JAMA Neurol"},{"issue":"1","key":"10.1016\/j.mcna.2024.09.001_bib35","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1212\/WNL.0000000000012191","article-title":"Clinical, neuroimmunologic, and CSF investigations in first episode psychosis","volume":"97","author":"Guasp","year":"2021","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.mcna.2024.09.001_bib36","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1164\/rccm.201603-0507OC","article-title":"Anti-N-methyl-D-aspartate receptor encephalitis in adult patients requiring intensive care","volume":"195","author":"De Montmollin","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1016\/j.mcna.2024.09.001_bib37","doi-asserted-by":"crossref","first-page":"e280","DOI":"10.1212\/NXI.0000000000000280","article-title":"Neuroleptic intolerance in patients with anti-NMDAR encephalitis","volume":"3","author":"Lejuste","year":"2016","journal-title":"Neurol Neuroimmunol Neuroinflammation"},{"issue":"8","key":"10.1016\/j.mcna.2024.09.001_bib38","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1093\/brain\/awh526","article-title":"Treatment-responsive limbic encephalitis identified by neuropil antibodies: MRI and PET correlates","volume":"128","author":"Ances","year":"2005","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.mcna.2024.09.001_bib39","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/S1474-4422(22)00431-8","article-title":"Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: international MOGAD Panel proposed criteria","volume":"22","author":"Banwell","year":"2023","journal-title":"Lancet Neurol"},{"issue":"3","key":"10.1016\/j.mcna.2024.09.001_bib40","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S1474-4422(19)30488-0","article-title":"Associations of paediatric demyelinating and encephalitic syndromes with myelin oligodendrocyte glycoprotein antibodies: a multicentre observational study","volume":"19","author":"Armangue","year":"2020","journal-title":"Lancet Neurol"},{"issue":"7","key":"10.1016\/j.mcna.2024.09.001_bib41","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1136\/jnnp-2020-325300","article-title":"Autoimmune encephalitis: proposed best practice recommendations for diagnosis and acute management","volume":"92","author":"Abboud","year":"2021","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"3","key":"10.1016\/j.mcna.2024.09.001_bib42","doi-asserted-by":"crossref","first-page":"E244","DOI":"10.1212\/WNL.0000000000006783","article-title":"A\u00a0score that predicts 1-year functional status in patients with anti-NMDA receptor encephalitis","volume":"92","author":"Balu","year":"2019","journal-title":"Neurology"},{"issue":"14","key":"10.1016\/j.mcna.2024.09.001_bib43","doi-asserted-by":"crossref","first-page":"e1489","DOI":"10.1212\/WNL.0000000000200021","article-title":"Neurofilament light chain levels in anti-NMDAR encephalitis and primary psychiatric psychosis","volume":"98","author":"Guasp","year":"2022","journal-title":"Neurology"},{"issue":"22","key":"10.1016\/j.mcna.2024.09.001_bib44","doi-asserted-by":"crossref","first-page":"e1997","DOI":"10.1212\/WNL.0000000000005605","article-title":"Long-term neuropsychological outcome following pediatric anti-NMDAR encephalitis","volume":"90","author":"De Bruijn","year":"2018","journal-title":"Neurology"}],"container-title":["Medical Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025712524001147?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025712524001147?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T23:41:42Z","timestamp":1762213302000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025712524001147"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S0025712524001147"],"URL":"https:\/\/doi.org\/10.1016\/j.mcna.2024.09.001","relation":{},"ISSN":["0025-7125"],"issn-type":[{"value":"0025-7125","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autoimmune Encephalitis","name":"articletitle","label":"Article Title"},{"value":"Medical Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mcna.2024.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}